Marijuana Moved to Schedule III: What It Actually Changes (and What It Doesn't)

Time-sensitive notice (as of late June 2026): The federal rescheduling process is actively evolving. A DOJ/DEA final order effective April 28, 2026, created the current two-tier framework. A broader DEA rescheduling hearing began June 29, 2026, and could result in further changes. Verify current DEA/DOJ status before making any decisions based on this article.

In April 2026, the federal government moved certain categories of marijuana from Schedule I to Schedule III under the Controlled Substances Act. Headlines called it a historic shift — and structurally, it is. But Schedule III is still a controlled substance, possession outside narrow legal channels is still a federal crime, and the change is narrower than most coverage suggested. Here is what actually changed and what did not.

What the April 2026 Order Did

The DOJ/DEA final order, published at 91 Fed. Reg. (Apr. 28, 2026) and effective that date, reclassified marijuana in a two-tier structure under 21 U.S.C. § 812:

• Schedule III now covers: (1) FDA-approved marijuana drug products, and (2) marijuana possessed and distributed under a qualifying state medical marijuana license.
• Schedule I still covers: all other marijuana — recreational, adult-use, and anything outside those two narrow categories — even in states that have fully legalized it.

The full text of the final order is available at federalregister.gov.

What "Schedule III" Actually Means

People sometimes describe Schedule III as "legal" or "decriminalized." That is wrong. Under the Controlled Substances Act, Schedule III substances are still controlled. Possessing a Schedule III substance without lawful authorization is a federal crime under 21 U.S.C. § 844, and manufacturing or distributing it without authorization is separately prohibited under federal law.

For ordinary consumers, the Schedule III designation for medical marijuana means federal enforcement focus may shift — but it does not grant any individual the right to possess marijuana lawfully under federal law simply because their state has a medical program. Whether a specific person's possession falls within the Schedule III channel depends on the exact facts: the product type, the license type, FDA approval status. Assume the narrowest interpretation applies until there is clearer federal guidance.

What the Order Did Not Change

The April 2026 order did not:

• Legalize recreational marijuana federally. Adult-use marijuana remains Schedule I regardless of state law.
• Remove federal collateral consequences. Federal housing programs, federal employment rules, federal firearms law, immigration consequences, and federal benefit rules all remain governed by federal marijuana law. Most of those regimes treat any Schedule I or Schedule III controlled substance as a basis for adverse action.
• Override the state-federal conflict. States that do not permit marijuana are unaffected. States with legalization still operate under the dual-sovereignty framework established in Gonzales v. Raich, 545 U.S. 1 (2005).
• Protect non-citizens. Immigration consequences of marijuana use — which flow from federal law — remain serious and largely unchanged. Non-citizens should consult an immigration attorney before relying on any aspect of the rescheduling.
• Resolve the firearms question. Marijuana remains a federally controlled substance, and the interplay with 18 U.S.C. § 922(g)(3) remains unsettled following United States v. Hemani, No. 24-1234 (U.S. June 18, 2026). See observed.org's Hemani article for the details of that narrow ruling.
• Change employer drug-testing authority. Employers — especially federal contractors and safety-sensitive employers — may still test for and discipline marijuana use. The ADA, at 42 U.S.C. § 12114, still does not require accommodation of marijuana use because it remains a federally controlled substance.

The Broader Rescheduling Hearing: What to Watch

A broader DEA rescheduling hearing began June 29, 2026. That proceeding could further change which substances are scheduled where, or establish new rules for the Schedule III framework. The outcome is not yet known as of late June 2026, and the status could shift materially. Anyone making a legal decision that depends on federal marijuana scheduling should check current DEA/DOJ status at the time of their decision, not rely on any article — including this one.

How This Interacts With State Law

Nothing in the April 2026 order preempts state marijuana law or grants states new authority. States that legalized marijuana did so under their own legislative power; states that have not are not required to change. Gonzales v. Raich, 545 U.S. 1 (2005), remains controlling: Congress can regulate marijuana under its commerce power even where state law permits it. The two legal systems continue to coexist.

For a medical marijuana patient in a state with a licensed medical program: the rescheduling may reflect a modest softening of the federal enforcement posture toward their activity. For a recreational user in a fully legalized state: nothing has changed federally. Their marijuana is still Schedule I.

Practical Implications by Area

Employment

Federal contractors, safety-sensitive workers, and federally regulated industries are unchanged. Private employers in states without employee protections retain wide discretion to discipline for marijuana use. See observed.org's employment and marijuana guide for state-by-state details.

Housing

Federally assisted housing rules remain tied to federal controlled-substance law. The Schedule III status for state-medical marijuana does not prevent a housing authority from acting on marijuana use in federally subsidized units.

Criminal Records

Past federal marijuana convictions are unaffected by the rescheduling. State record-clearing processes remain governed by state law. See observed.org's record-clearing guides for state-specific information.

What You Can Do

• Do not assume rescheduling equals legalization. Even Schedule III requires lawful authorization to possess. Ordinary state-program marijuana is not federally authorized, and recreational marijuana is still Schedule I.
• Monitor the DEA/DOJ for further changes. The June 29, 2026 hearing could alter the framework significantly. Check federalregister.gov and official DEA announcements.
• Know which tier applies to your marijuana. FDA-approved products and state-licensed medical marijuana occupy a different federal legal position than recreational use. Recreational use is still Schedule I federally.
• Non-citizens: get immigration advice now. The rescheduling did not remove immigration risk for marijuana use. Consult an immigration attorney before using marijuana or before any related encounter with authorities.
• Check your employer's policies and your state's law. State employment protections, employer policies, and federal carve-outs all interact independently of the federal scheduling change.

This is general legal information, not legal advice. Federal marijuana law is evolving rapidly. The status described here reflects the law as of late June 2026 and could change as the DEA rescheduling hearing proceeds. Always verify the current federal schedule status through official DEA/DOJ sources and consult a licensed attorney in your state for advice specific to your situation.